期刊文献+

右美托咪定对卵巢癌细胞相关生物学行为的影响 被引量:16

Effects of dexmedetomidine on the biological behavior of ovarian cancer cells
下载PDF
导出
摘要 目的探讨右美托咪定对卵巢癌细胞相关生物学行为的影响。方法通过CCK-8检测右美托咪定对卵巢癌SKOV3细胞活性的影响;通过流式细胞术FITC-Annexin V/PI双染色验证右美托咪定能否诱导SKOV3卵巢癌细胞凋亡;划痕实验检测右美托咪定对SKOV3卵巢癌细胞迁移能力的影响;Transwell侵袭实验检测右美托咪定对SKOV3卵巢癌细胞侵袭能力的影响。结果右美托咪定能降低SKOV3卵巢癌细胞的活性,且呈剂量依赖性和时间依赖性;右美托咪定能诱导SKOV3卵巢癌细胞凋亡,当右美托咪定浓度达到10、100 nmol/L,凋亡率分别为8.21%和8.30%;右美托咪定能减弱SKOV3卵巢癌细胞的迁移能力和侵袭能力。结论右美托咪定能通过诱导细胞凋亡抑制SKOV3卵巢癌细胞的活性,减弱细胞的迁移和侵袭能力。 Objective To investigate the effect of dexmedetomidine on the biological behavior of ovarian cancer cells. Methods The effect of dexmedetomidine on the activity of ovarian cancer SKOV3 cells was detected by CCK-8 kit. Flow cytometry FITC-Annexin V/PI double staining was used to test whether dexmedetomidine could in- duce the apoptosis of SKOV3 ovarian cancer cell. The effect of dexmedetomidine on the migration ability of SKOV3 o- varian cancer cells was examined by scratch healing experiment. The effect of dexmedetomidine on the invasion ability of SKOV3 ovarian cancer cells was detected by Transwell invasion assay. Results Dexmedetomidine could decreasethe activity of SKOV3 ovarian cancer cells in a dose-dependent and time-dependent manner. Dexmedetomidine could induce the apoptosis of SKOV3 ovarian cancer cells. When the concentration of dexmedetomidine reached 10 and 100 nmol/L,the apoptotic rates were 8.21% and 8.30% respectively. Dexmedetomidine could decrease the migration and invasion ability of SKOV3 ovarian cancer cells. Conclusion Dexmedetomidine can inhibit the activity of SKOV3 o- varian cancer cells by inducing apoptosis, and also can decrease its migration and invasion ability.
作者 连红梅 姜丽华 LIAN Hong-mei;JIANG Li-hua(Department of Anesthesiology, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Chin)
出处 《实用药物与临床》 CAS 2018年第4期369-373,共5页 Practical Pharmacy and Clinical Remedies
基金 河南省科技厅科技攻关项目(162102310131)
关键词 右美托咪定 卵巢癌 凋亡 迁移 侵袭 Dexmedetomidine Ovarian cancer Apoptosis Migration Invasion
  • 相关文献

参考文献9

二级参考文献120

  • 1陈萍,李坚,朱文静,杭建明.肺癌患者纤维支气管镜活检标本K-ras基因突变的检测及其临床意义[J].江苏大学学报(医学版),2013,23(6):509-512. 被引量:1
  • 2重症加强治疗病房病人镇痛和镇静治疗指南(2006)[J].中国实用外科杂志,2006,26(12):893-901. 被引量:211
  • 3GUO TZ, POREE L, GOLDEN W J, et al. Antinociceptive res- ponse to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat[J]. Anesthesiology, 1996, 85 (4) : 846-852.
  • 4NELSON LE. LU J. GUO T, et al. The alpha2-adrenoeeptor agonist dexmedetomidine converges on an endogenous sleep- promoting pathway to exert its sedative effects[J]. Anesthesiology, 2003, 98(2): 428-436.
  • 5KENDIG JJ, SAVOLA MK, WOODLEY SJ. et al. Alpha 2- adrenoeeptors inhibit a noeiceptive response in neonatal rat spinal cord[J]. Eur J Pharmacol, 1991, 192(2) : 293-300.
  • 6LAKHLANI PP, MacMILLAN LB, GUO TZ, et al. Substitution of a mutant alpha2a-adrenergic receptor via "hit and run"gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo[J]. Proc Natl Acad Sci, 1997, 94(18) : 9950-9955.
  • 7POREE LR, GUO TZ, KINGERY WS, et al. The analgesic potency of dexmedetomidine is enhanced after nerve injury.: a possible role for peripheral alpha2-adrenoceptors[J]. Anesth Analg, 1998, 87(4): 941-948.
  • 8BHANA N, GOA KL, McCLELLAN KJ. Dexmedetomidine[J]. Drugs, 2000, 59(2): 263-270.
  • 9JAAKOLA ML, ALI-MELKKILA TA, KANTO A, et al. Dex- medetomidine reduces intraocular pressure,intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgezy[J]. Br J Anaesth, 1992, 68(6) : 570-575.
  • 10LAWRENCE CJ, de LANGE S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri- operative haemodynamic stability[J]. Anaesthesia, 1997, 52(8) : 736-744.

共引文献407

同被引文献98

引证文献16

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部